MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Property and equipment,gross$16,215,506 Due from relatedparties ...$763,388 Cash and cashequivalents$681,480 Restricted cash$645,505 Prepaid expense andother current assets$346,616 Short-term investments$64,354 Property and equipment,net$12,835,409 Total current assets$2,501,343 Operating leaseright-of-use assets$1,913,278 Long-term investments$1,878,465 Prepayment for long-terminvestments$1,124,842 Prepayment for assetacquisition$691,900 Other non-currentassets$116,966 Less accumulateddepreciation$3,380,097 Total assets$21,062,203 Total liabilities andequity$21,062,203 Total equity$13,297,480 Total liabilities$7,764,723 Total stockholdersequity$11,111,861 Noncontrolling interest$2,185,619 Total currentliabilities$6,163,976 Operating lease liability non-current$1,600,747 Accumulated deficit-$76,858,361 Treasury stock$8,909,691 Additional paid-in capital$96,008,258 Accrued expenses andother current...$4,161,629 Short-term bank and otherloans$755,512 Convertible notes payable third parties, net$559,010 Operating leaseliabilities current$317,557 Convertible notes payable related parties,...$240,000 Due to relatedparties-Related Party$105,704 Contract liabilities$12,600 Tax payable$11,964 Accumulated othercomprehensive income$487,602 Stock to be issued$359,000 Common stock, 0.001 parvalue, 100,000,000...$25,053
Balance Sheet
source: myfinsight.com

ABVC BIOPHARMA, INC. (ABVC)

ABVC BIOPHARMA, INC. (ABVC)